Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-01-02 May Larry Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2012-08-16 May Larry Alan Chief Financial Officer Grant or award +1,500 64,618
2012-08-16 May Larry Alan Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −1,500 0
2012-04-26 May Larry Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +56,250 56,250

Page 1 of 1 · 4 trades